A Win For Harpoon Therapeutics, Inc.
Fri, Jun 03, 2022 at 05:30 PM
Harpoon Therapeutics, Inc. (HARP:NASDAQ) jumped higher at $2.4, a gain of 21.2%. On Thu, Jun 02, 2022, HARP:NASDAQ touched a New 2-Week Intraday Low of $1.92. The stock got featured on our News Catalysts scanner on Thu, May 26, 2022 at 05:46 PM in the 'BIOTECH' category. From Thu, May 19, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
About Harpoon Therapeutics, Inc. (HARP:NASDAQ)
Harpoon Therapeutics Inc is a clinical-stage immunotherapy company. It is engaged in developing a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The company's pipeline products include HPN424, HPN536, HPN217, and others.
Top 10 Gainers:
- Turning Point Therapeutics, Inc. (TPTX:NASDAQ), 118.35%
- Energy Focus, Inc. (EFOI:NASDAQ), 48.65%
- Galecto Inc. (GLTO:NASDAQ), 35.17%
- Yumanity Therapeutics Inc. (YMTX:NASDAQ), 33.96%
- Houston American Energy Corp. (HUSA:NYSEMKT), 27.54%
- Amylyx Pharmaceuticals Inc. (AMLX:NASDAQ), 26.41%
- Forian Inc. (FORA:NASDAQ), 24.23%
- Integrated Media Technology Limited (IMTE:NASDAQ), 22.88%
- Eros STX Global Corporation A (ESGC:NYSE), 22.18%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 21.21%